Pompe Disease Myositis Hereditary myopathies Spinal muscular atrophy
Conditions
Interventions
Group 1: Observation group: Examination of muscles with MSOT and determination of clinical parameters. Includes healthy non-myopathic controls as well as patients with muscle diseases.
Sponsors
Universitätsmedizin Göttingen, Klinik für Neurologie
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Certain diagnosis of a neuromuscular disease evaluated in this study. Able to give consent to the study
Exclusion criteria
Exclusion criteria: Uncertain neuromuscular disease, diagnosis of neuromuscular disease not evaluated in this study. Inability to give consent Pregnancy Tattoos in the examinated skin area
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluation of differences in muscle structure profiles between different neuromuscular diseases (SMA, hereditary myopathies, myositis, Pompe Disease) in MSOT and possibility of differentiating between disease entitites. | — |
Secondary
| Measure | Time frame |
|---|---|
| Comparison of quantitative glycogen, lipide, collagen and haemoglobin portions between different neuromuscular diseases compared to healthy controls. Evaluation of correlation between structural markers and disease severity. | — |
Countries
Germany
Contacts
Public ContactJana Zschüntzsch
Universitätsmedizin Göttingen, Klinik für Neurologie
Outcome results
None listed